That cytoskeletal alterations contribute to alterations in the LEBS sign was supported by our obtaining that pharmacological disruption of the cytoskeleton by colchicine negates the observable distinction in LEBS amongst handle and precancerous cells (Fig. four)
We independently verified the modulation of these candidate genes in the AOM rat product utilizing specific TaqMan gene expression assays, hence, confirming the results of the PCR array (data not…